Europe Infection Surveillance Solution Systems Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Europe Infection Surveillance Solution Systems Market Size

• The Europe infection surveillance solution systems market size was valued at USD 540.00 million in 2025 and is expected to reach USD 1,807.30 million by 2033, at a CAGR of 16.30% during the forecast period
• The market growth is largely fueled by increasing adoption of digital health‑IT infrastructure across hospitals and clinics, growing emphasis on infection control, and rising demand for real‑time surveillance of hospital-acquired infections (HAIs) across Europe
• Furthermore, rising demand from hospitals and other healthcare facilities for efficient, automated, and integrated infection monitoring solutions is establishing infection surveillance systems as the preferred choice for infection prevention and control. These converging factors are accelerating the uptake of infection surveillance solutions, thereby significantly boosting the industry's growth

Europe Infection Surveillance Solution Systems Market Analysis

• Infection surveillance solution systems, offering real-time monitoring and digital reporting of hospital-acquired infections (HAIs) and other healthcare-associated infections, are increasingly vital components of modern healthcare facilities in both public and private hospitals due to their enhanced accuracy, automated data collection, and seamless integration with electronic health records (EHRs) and hospital IT infrastructure
• The escalating demand for infection surveillance systems is primarily fueled by growing regulatory focus on infection prevention, rising awareness of HAIs, increasing adoption of digital health technologies, and the need for efficient, automated compliance reporting
• Germany dominated the market with the largest revenue share of 35.2% in 2025, characterized by well-established healthcare infrastructure, high adoption of digital health solutions, and strong presence of key industry players, with hospitals experiencing substantial growth in infection surveillance deployments driven by innovations in software analytics and integrated reporting platforms
• Poland is expected to be the fastest-growing country in the market during the forecast period due to increasing healthcare digitization, rising hospital budgets, and growing initiatives for infection control programs
• Software segment dominated the infection surveillance solutions market with a market share of 74.5% in 2025, driven by its ability to provide real-time analytics, automated alerts, and seamless integration with existing hospital IT systems

Report Scope and Europe Infection Surveillance Solution Systems Market Segmentation

Europe Infection Surveillance Solution Systems Market Trends

“AI, IoT & Real-Time Analytics Integration”

• A significant and accelerating trend in the Europe infection surveillance market is the integration of artificial intelligence (AI), Internet of Things (IoT) sensors, and real-time analytics into hospital infection-control systems, enhancing detection and response capabilities
• For instance, hospitals in Germany and France are deploying AI-enabled platforms that monitor electronic health records (EHR) and IoT devices to predict and alert staff about potential hospital-acquired infection (HAI) risks before outbreaks occur
• AI integration allows systems to identify unusual infection patterns, optimize hygiene workflows, and provide automated alerts to staff, improving patient safety and operational efficiency across healthcare facilities
• Real-time analytics and cloud-based platforms facilitate centralized monitoring across multiple hospitals and surgical centers, enabling faster decision-making and data-driven infection prevention strategies
• Interoperability with electronic medical devices and surgical equipment is becoming a key feature, allowing seamless data flow and enhancing system accuracy for infection surveillance
• Predictive modeling capabilities are being incorporated into newer platforms to forecast potential outbreak hotspots, enabling preventive measures and resource allocation in advance
• This trend toward intelligent, interconnected, and proactive infection surveillance is transforming European hospitals’ approach from reactive infection management to predictive, preventative healthcare practices
• The demand for systems with seamless AI and IoT integration is growing rapidly, as healthcare providers increasingly prioritize patient safety, operational efficiency, and compliance with regulatory guidelines

Europe Infection Surveillance Solution Systems Market Dynamics

Driver

“Rising Prevalence of HAIs & Regulatory Pressure”

• The growing prevalence of hospital-acquired infections (HAIs) across Europe is a major driver for the adoption of infection surveillance solutions, creating urgency for early detection and intervention
• For instance, rising antimicrobial resistance (AMR) and multidrug-resistant infections are prompting hospitals to deploy advanced pathogen-tracking systems for proactive monitoring
• Strict regulatory frameworks, accreditation standards, and national infection-control policies across countries such as Germany, the UK, and France compel hospitals to implement systematic surveillance and real-time reporting solutions
• Increasing volumes of complex surgeries and medical procedures heighten the risk of HAIs, driving demand for integrated surveillance systems linked to surgical workflows and sterilization processes
• As healthcare providers aim to reduce infection rates, improve patient safety, and meet compliance mandates, adoption of infection surveillance solutions continues to accelerate
• Investments in specialty clinics and ambulatory surgical centers are also rising, further expanding the market for infection surveillance systems across diverse healthcare settings
• Government initiatives and funding programs supporting hospital digitization and infection control infrastructure further accelerate adoption across Europe
• Collaboration between healthcare institutions and technology providers to implement innovative solutions, such as AI-powered monitoring and cloud-based reporting, is expanding market penetration

Restraint/Challenge

“Data Integration, Cost & Infrastructure Challenge”

• A key challenge in the Europe infection surveillance market is integration with legacy hospital IT systems, as many facilities still rely on older record-keeping methods, complicating deployment of modern surveillance platforms
• For instance, smaller hospitals and clinics often face budget constraints, limiting their ability to implement high-cost AI and IoT-based infection surveillance solutions
• Shortages of trained staff in IT management and infection-control protocols hinder effective use and maintenance of advanced surveillance systems
• Compliance with data privacy regulations such as GDPR, along with concerns over patient data security, adds complexity and slows adoption of cloud-based or networked solutions
• Variations in hospital infrastructure across countries from highly equipped facilities in Germany and France to under-resourced clinics in Eastern Europe result in uneven adoption and market penetration
• High upfront costs for software licensing, IoT sensors, and maintenance services can discourage smaller hospitals from investing in advanced surveillance solution
• Resistance to change from healthcare staff accustomed to manual infection control methods may slow adoption, necessitating training programs and change management initiative
• Addressing these challenges through cost-effective solutions, staff training, and secure, interoperable platforms will be essential for sustained growth of infection surveillance solutions in Europe

Europe Infection Surveillance Solution Systems Market Scope

The market is segmented on the basis of type, communication protocol, unlocking mechanism, and application.

• By Products

On the basis of products, the Europe infection surveillance solution systems market is segmented into software and services. The software segment dominated the market in 2025 with a market share of 74.5%, driven by its ability to provide real-time analytics, predictive alerts, and automated reporting for hospital-acquired infections (HAIs). Hospitals and surgical centers increasingly rely on software platforms to integrate data from multiple sources, including electronic health records (EHRs), IoT-enabled devices, and laboratory systems, enabling efficient infection tracking. Software solutions also allow centralized monitoring across multiple facilities, improving decision-making for infection control teams. The increasing need for compliance with regulatory standards and infection-prevention mandates further strengthens software adoption. Moreover, software platforms offer scalability and interoperability, allowing healthcare facilities to expand surveillance capabilities without major infrastructure changes. Advanced features such as AI-based predictive modeling and integration with surgical workflows make software the preferred choice for large hospitals.

The services segment is expected to witness the fastest growth from 2026 to 2033, fueled by rising demand for professional support in system implementation, training, maintenance, and compliance management. Services include consulting, installation, system updates, and technical support, which are critical for hospitals and clinics with limited IT expertise. Outsourcing these services enables healthcare facilities to maintain system efficiency while ensuring adherence to infection control protocols. Increasing investments in long-term care facilities and specialty clinics are driving the need for outsourced services. In addition, cloud-based surveillance solutions often require continuous monitoring and maintenance, which boosts the demand for service contracts. The adoption of services is further accelerated in smaller hospitals and clinics that cannot afford dedicated IT staff for system management.

• By Infection Type

On the basis of infection type, the market is segmented into Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Central Line-Associated Bloodstream Infections (CLABSI), Catheter Associated Urinary Tract Infection (CAUTI), and others. The Surgical Site Infections (SSI) segment dominated the market in 2025, owing to the high prevalence of postoperative infections and the critical need for monitoring in surgical departments. SSIs can lead to prolonged hospital stays, increased treatment costs, and severe complications, prompting hospitals to adopt advanced surveillance solutions. Software platforms provide real-time tracking, risk prediction, and compliance reporting, which are particularly useful in surgical wards. Hospitals also integrate SSI surveillance with sterilization and surgical workflow monitoring, enhancing overall patient safety. Increasing number of complex surgeries in countries such as Germany, France, and the UK supports the sustained demand for SSI-focused solutions. The segment’s dominance is reinforced by strict regulatory reporting requirements and hospital accreditation standards related to postoperative infections.

The Urinary Tract Infection (UTI) segment is expected to witness the fastest growth during 2026–2033, driven by the rising incidence of catheter-associated infections in hospitals and long-term care facilities. Surveillance solutions for UTIs help in early detection, automated alert generation, and real-time reporting, reducing patient complications and readmissions. The adoption is further fueled by regulatory initiatives emphasizing infection prevention in long-term care centers. Increasing use of catheterized patients in aging populations across Europe supports the growth of this segment. Integration of UTI surveillance with electronic health records and nursing workflows enhances monitoring efficiency and compliance. Rising awareness about the economic and clinical impact of UTIs is encouraging healthcare providers to implement specialized monitoring solutions.

• By End User

On the basis of end users, the market is segmented into hospitals, long-term care facilities, clinics, ambulatory surgical centres, academic institutes, and others. The hospitals segment dominated the market in 2025, due to their large patient volume, complexity of care, and high susceptibility to hospital-acquired infections. Hospitals implement infection surveillance systems across surgical wards, ICUs, and general patient rooms to ensure compliance with strict regulatory standards and accreditation requirements. Centralized software platforms allow hospital administrators to monitor infections across multiple departments, improving operational efficiency. Large hospitals also invest in predictive analytics and AI-based modules to prevent outbreaks and enhance patient safety. The segment benefits from higher budgets and the presence of dedicated infection control teams capable of leveraging advanced surveillance technologies. Ongoing initiatives to digitalize hospital operations further strengthen adoption of infection surveillance systems.

The long-term care facilities segment is expected to witness the fastest growth from 2026 to 2033, driven by the rising elderly population and increased vulnerability to infections in such settings. These facilities require real-time monitoring and automated alert systems to manage infections among residents effectively. Limited on-site IT expertise and smaller operational budgets encourage outsourcing of software and service solutions. Regulatory mandates in countries such as Germany, France, and the UK are pushing long-term care facilities to implement systematic infection monitoring programs. Integration with electronic health records and routine care workflows enhances efficiency and reduces manual tracking errors. Growing investments and government initiatives to improve infection prevention infrastructure are further boosting adoption in long-term care facilities.

Europe Infection Surveillance Solution Systems Market Regional Analysis

• Germany dominated the market with the largest revenue share of 35.2% in 2025, characterized by well-established healthcare infrastructure, high adoption of digital health solutions, and strong presence of key industry players, with hospitals experiencing substantial growth in infection surveillance deployments driven by innovations in software analytics and integrated reporting platforms
• Healthcare providers in Germany highly value real-time monitoring, automated reporting, and predictive analytics offered by infection surveillance systems, enabling early detection and management of hospital-acquired infections (HAIs)
• This widespread adoption is further supported by substantial investments in hospital IT infrastructure, government initiatives promoting patient safety, and the presence of key industry players, establishing infection surveillance systems as the preferred solution for both public and private healthcare facilities

The Germany Infection Surveillance Solution Systems Market Insight

The Germany infection surveillance solution systems market is expected to expand at a considerable CAGR during the forecast period, fueled by the country’s advanced healthcare infrastructure, high regulatory standards, and emphasis on innovation in medical technology. Hospitals and surgical centers are increasingly adopting AI-enabled surveillance systems for early detection of HAIs and to ensure compliance with stringent reporting requirements. Germany’s focus on sustainability and technological advancement promotes the deployment of integrated, automated solutions. The well-developed hospital IT infrastructure, along with investments in training and predictive analytics platforms, further supports market growth. In addition, the presence of key industry players and strong R&D capabilities are accelerating the adoption of cutting-edge infection surveillance solutions.

U.K. Infection Surveillance Solution Systems Market Insight

The U.K. infection surveillance solution systems market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising awareness of patient safety, strict infection control regulations, and increasing adoption of digital health platforms. Hospitals and clinics are focusing on AI-powered monitoring systems that provide real-time alerts and predictive analytics for HAIs. Concerns regarding healthcare-associated infections and the need for improved compliance with NHS standards are encouraging providers to invest in advanced surveillance solutions. The U.K.’s strong healthcare IT infrastructure and widespread acceptance of connected medical technologies further stimulate market growth. In addition, integration with electronic health records and other hospital systems enhances operational efficiency and monitoring capabilities.

France Infection Surveillance Solution Systems Market Insight

The France infection surveillance solution systems market is expected to expand steadily during the forecast period, driven by government initiatives for infection prevention, growing hospital digitization, and rising investments in patient safety. Hospitals and long-term care facilities are adopting real-time surveillance platforms to monitor surgical site infections, bloodstream infections, and urinary tract infections. The integration of AI and cloud-based analytics enables faster detection of infection trends and supports compliance with regulatory standards. Increasing demand for predictive monitoring, interoperability with existing hospital IT systems, and the focus on quality healthcare outcomes are key factors supporting growth. The market is also strengthened by collaborations between healthcare providers and technology vendors to implement innovative infection surveillance solutions.

Poland Infection Surveillance Solution Systems Market Insight

The Poland infection surveillance solution systems market is expected to witness the fastest growth during the forecast period, fueled by ongoing healthcare digitization, rising hospital budgets, and government initiatives to strengthen infection control. Hospitals, clinics, and long-term care facilities are increasingly deploying software and service-based surveillance solutions for real-time infection monitoring. Rising awareness about hospital-acquired infections and compliance requirements is encouraging the adoption of predictive and automated systems. The growing elderly population and the need to manage infections in long-term care centers further drive demand. In addition, partnerships with technology providers and investments in training and IT infrastructure are supporting rapid market expansion.

Europe Infection Surveillance Solution Systems Market Share

The Europe Infection Surveillance Solution Systems industry is primarily led by well-established companies, including:

• BIOMÉRIEUX (France)
• ICNET International Ltd (UK)
• Baxter (U.S.)
• RLDatix (UK)
• Wolters Kluwer N.V. (Netherlands)
• GOJO Industries, Inc. (U.S.)
• Ecolab Inc. (U.S.)
• Medexter Healthcare GmbH (Austria)
• CenTrak, Inc. (U.S.)
• Clinisys Group Ltd (U.S.)
• Deb Group Ltd (UK)
• Asolva Inc (U.S.)
• Premier Inc. (U.S.)
• Vecna Technologies, Inc. (U.S.)
• BD(U.S.)
• PeraHealth Inc (U.S.)
• PointClickCare Corp (Canada)
• STANLEY Healthcare Solutions (U.S.)
• VigiLanz Corporation (U.S.)
• CKM Healthcare Inc (Canada)

What are the Recent Developments in Europe Infection Surveillance Solution Systems Market?

• In August 2025, NeoIPC published its first “Surveillance Reference Report”, based on data from 26 neonatal units across Europe, providing a benchmarking dataset on infection rates among very preterm and low‑birth‑weight infants a milestone enabling NICUs to compare performance and improve infection‑control practices
• In March 2025, European Centre for Disease Prevention and Control (ECDC) released version 2.3 of its protocol for surveillance of surgical site infections (SSIs) and prevention indicators in European hospitals, standardising definitions, data collection and reporting procedures across member states
• In May 2024, the European Centre for Disease Prevention and Control (ECDC) reported that approximately 4.3 million patients in EU/EEA hospitals acquire at least one healthcare‑associated infection (HAI) annually, based on its 2022‑2023 point‑prevalence survey highlighting the scale of the HAI challenge and reinforcing the urgency for enhanced surveillance systems
• In November 2023, the NeoIPC consortium launched a new surveillance toolkit for neonatal intensive care units (NICUs) to track and prevent hospital‑acquired infections (HAIs) in high-risk newborns, including preterm infants enabling data collection on infection rates and risk factors tailored for neonatal care
• In October 2023, WHO/Europe (in coordination with ECDC) launched the European Respiratory Virus Surveillance Summary (ERVISS) a new platform integrating surveillance data for influenza, COVID‑19, RSV and other respiratory viruses across European countries, signalling a shift toward more integrated, multi‑pathogen surveillance systems

SKU-44683